Experimental antiasthmatic activity of RWJ 22108

A bronchoselective calcium entry blocker

David M. Ritchie, Thomas Kirchner, John B. Moore, John H. Dodd, Tahir Ahmed, David W. Anderson, Robert J. Capetola

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

RWJ 22108 (N-benzyl-N-methylaminoethyl 9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1,1-dioxothiacyclohepteno-[3,2-b]pyridine-8-carboxylate) is a new bronchoselective calcium entry blocker with potential use as an antiasthmatic agent. Previous studies have shown that RWJ 22108 is a po-tent calcium entry blocker in vitro and demonstrates tissue selectivity for air-way smooth muscle over vascular smooth muscle. The current study demon-strates the in vivo activity of RWJ 22108 in several different models of airway obstruction and asthma. RWJ 22108 relaxes preconstricted airways in dogs with little effect on blood pressure when administered by aerosol. In addition, it inhibits airway obstruction induced by antigen, histamine and exogenous leu-kotriene D4 in guinea pigs. In a conscious sheep model of allergic asthma, aero-sol RWJ 22108 inhibits antigen-induced early and late phase airway obstruction and also the cellular infiltration associated with late phase. Total leukotrienes production is decreased in the guinea pig model probably as a result of fewer inflammatory cells infiltrating the lungs as shown in the sheep model of late phase. These data suggest that RWJ 22108 may have pharmacological potential in the clinical management of asthma.

Original languageEnglish (US)
Pages (from-to)274-282
Number of pages9
JournalInternational Archives of Allergy and Immunology
Volume100
Issue number3
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Anti-Asthmatic Agents
Calcium
Airway Obstruction
Asthma
Sheep
Guinea Pigs
Antigens
Leukotrienes
Polymethyl Methacrylate
RWJ 22108
Aerosols
Vascular Smooth Muscle
Histamine
Smooth Muscle
Air
Pharmacology
Dogs
Blood Pressure
Lung

Keywords

  • Airway obstruction
  • Asthma
  • Calcium entry blocker
  • RWJ 22108

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Ritchie, D. M., Kirchner, T., Moore, J. B., Dodd, J. H., Ahmed, T., Anderson, D. W., & Capetola, R. J. (1993). Experimental antiasthmatic activity of RWJ 22108: A bronchoselective calcium entry blocker. International Archives of Allergy and Immunology, 100(3), 274-282. https://doi.org/10.1159/000236424

Experimental antiasthmatic activity of RWJ 22108 : A bronchoselective calcium entry blocker. / Ritchie, David M.; Kirchner, Thomas; Moore, John B.; Dodd, John H.; Ahmed, Tahir; Anderson, David W.; Capetola, Robert J.

In: International Archives of Allergy and Immunology, Vol. 100, No. 3, 1993, p. 274-282.

Research output: Contribution to journalArticle

Ritchie, DM, Kirchner, T, Moore, JB, Dodd, JH, Ahmed, T, Anderson, DW & Capetola, RJ 1993, 'Experimental antiasthmatic activity of RWJ 22108: A bronchoselective calcium entry blocker', International Archives of Allergy and Immunology, vol. 100, no. 3, pp. 274-282. https://doi.org/10.1159/000236424
Ritchie, David M. ; Kirchner, Thomas ; Moore, John B. ; Dodd, John H. ; Ahmed, Tahir ; Anderson, David W. ; Capetola, Robert J. / Experimental antiasthmatic activity of RWJ 22108 : A bronchoselective calcium entry blocker. In: International Archives of Allergy and Immunology. 1993 ; Vol. 100, No. 3. pp. 274-282.
@article{6481b7dbadeb4d708a2c41dcefa9c601,
title = "Experimental antiasthmatic activity of RWJ 22108: A bronchoselective calcium entry blocker",
abstract = "RWJ 22108 (N-benzyl-N-methylaminoethyl 9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1,1-dioxothiacyclohepteno-[3,2-b]pyridine-8-carboxylate) is a new bronchoselective calcium entry blocker with potential use as an antiasthmatic agent. Previous studies have shown that RWJ 22108 is a po-tent calcium entry blocker in vitro and demonstrates tissue selectivity for air-way smooth muscle over vascular smooth muscle. The current study demon-strates the in vivo activity of RWJ 22108 in several different models of airway obstruction and asthma. RWJ 22108 relaxes preconstricted airways in dogs with little effect on blood pressure when administered by aerosol. In addition, it inhibits airway obstruction induced by antigen, histamine and exogenous leu-kotriene D4 in guinea pigs. In a conscious sheep model of allergic asthma, aero-sol RWJ 22108 inhibits antigen-induced early and late phase airway obstruction and also the cellular infiltration associated with late phase. Total leukotrienes production is decreased in the guinea pig model probably as a result of fewer inflammatory cells infiltrating the lungs as shown in the sheep model of late phase. These data suggest that RWJ 22108 may have pharmacological potential in the clinical management of asthma.",
keywords = "Airway obstruction, Asthma, Calcium entry blocker, RWJ 22108",
author = "Ritchie, {David M.} and Thomas Kirchner and Moore, {John B.} and Dodd, {John H.} and Tahir Ahmed and Anderson, {David W.} and Capetola, {Robert J.}",
year = "1993",
doi = "10.1159/000236424",
language = "English (US)",
volume = "100",
pages = "274--282",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Experimental antiasthmatic activity of RWJ 22108

T2 - A bronchoselective calcium entry blocker

AU - Ritchie, David M.

AU - Kirchner, Thomas

AU - Moore, John B.

AU - Dodd, John H.

AU - Ahmed, Tahir

AU - Anderson, David W.

AU - Capetola, Robert J.

PY - 1993

Y1 - 1993

N2 - RWJ 22108 (N-benzyl-N-methylaminoethyl 9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1,1-dioxothiacyclohepteno-[3,2-b]pyridine-8-carboxylate) is a new bronchoselective calcium entry blocker with potential use as an antiasthmatic agent. Previous studies have shown that RWJ 22108 is a po-tent calcium entry blocker in vitro and demonstrates tissue selectivity for air-way smooth muscle over vascular smooth muscle. The current study demon-strates the in vivo activity of RWJ 22108 in several different models of airway obstruction and asthma. RWJ 22108 relaxes preconstricted airways in dogs with little effect on blood pressure when administered by aerosol. In addition, it inhibits airway obstruction induced by antigen, histamine and exogenous leu-kotriene D4 in guinea pigs. In a conscious sheep model of allergic asthma, aero-sol RWJ 22108 inhibits antigen-induced early and late phase airway obstruction and also the cellular infiltration associated with late phase. Total leukotrienes production is decreased in the guinea pig model probably as a result of fewer inflammatory cells infiltrating the lungs as shown in the sheep model of late phase. These data suggest that RWJ 22108 may have pharmacological potential in the clinical management of asthma.

AB - RWJ 22108 (N-benzyl-N-methylaminoethyl 9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1,1-dioxothiacyclohepteno-[3,2-b]pyridine-8-carboxylate) is a new bronchoselective calcium entry blocker with potential use as an antiasthmatic agent. Previous studies have shown that RWJ 22108 is a po-tent calcium entry blocker in vitro and demonstrates tissue selectivity for air-way smooth muscle over vascular smooth muscle. The current study demon-strates the in vivo activity of RWJ 22108 in several different models of airway obstruction and asthma. RWJ 22108 relaxes preconstricted airways in dogs with little effect on blood pressure when administered by aerosol. In addition, it inhibits airway obstruction induced by antigen, histamine and exogenous leu-kotriene D4 in guinea pigs. In a conscious sheep model of allergic asthma, aero-sol RWJ 22108 inhibits antigen-induced early and late phase airway obstruction and also the cellular infiltration associated with late phase. Total leukotrienes production is decreased in the guinea pig model probably as a result of fewer inflammatory cells infiltrating the lungs as shown in the sheep model of late phase. These data suggest that RWJ 22108 may have pharmacological potential in the clinical management of asthma.

KW - Airway obstruction

KW - Asthma

KW - Calcium entry blocker

KW - RWJ 22108

UR - http://www.scopus.com/inward/record.url?scp=0027474330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027474330&partnerID=8YFLogxK

U2 - 10.1159/000236424

DO - 10.1159/000236424

M3 - Article

VL - 100

SP - 274

EP - 282

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 3

ER -